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Development and implementation of a nurse-led allergy
clinic model in primary care: feasibility trial protocol
Margaret Kelman1, Victoria Hammersley 1*, Marilyn Kendall1, Mome Mukherjee 1, Lynn Morrice1, Susan Harley1,
Jürgen Schwarze1,2 and Aziz Sheikh1
In the United Kingdom, there are acknowledged short comings in allergy care provision for patients seen in primary care. There is a
lack of allergy training for healthcare professionals and this leads to inappropriate referrals to the limited number of allergy
specialists. The primary aims of this study are to assess the feasibility of delivering and evaluating a new nurse-led allergy service in
primary care, measured by recruitment, retention and quality of life. This is a single arm feasibility trial in which up to 250
participants referred to the nurse-led allergy clinic will receive the intervention and complete 6–12 weeks follow-up before being
referred back to their usual care. Primary outcomes for this study will be establishment of clinics, recruitment and retention rates,
and estimates of change in disease-speciﬁc quality of life measures. Secondary outcomes will be acceptability of the new service to
participants/carers and healthcare professionals. A sample of participants and professional stakeholders will take part in more in-
depth semi-structured qualitative interviews. Data from this feasibility trial will be used to inform plans for a pilot randomised
controlled trial of nurse-led allergy clinics.
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INTRODUCTION
The incidence and prevalence of allergic diseases has increased
substantially over recent decades, and the United Kingdom has
one of the highest rates of allergy in the western world.1 Allergic
conditions affect approximately one in three people in Scotland at
some point in their lives2 and the prevalence is thought to be
even higher in children and young people, with an estimated 50%
of the population now affected.3 Allergic conditions cost the UK’s
national health services over £1 billion per annum.4
The term allergy covers a broad range of clinical conditions that
share a common pathophysiology. The most common conditions
and those responsible for the greatest healthcare utilisation
include atopic eczema/dermatitis (henceforth atopic eczema),
food allergy, asthma, allergic rhinitis, allergic conjunctivitis,
urticaria and anaphylaxis. The majority of cases of allergy in the
United Kingdom are managed within primary care.5 Specialist
allergy care provision is patchy, but where it exists, evidence
suggests that there are often unnecessary referrals to secondary
care for conditions that could be dealt with in primary care
settings.5 This in turn reﬂects important gaps in undergraduate
and postgraduate training of general practitioners (GPs).6 There
have been a number of national calls and initiatives aimed at
improving allergy care provision in the United Kingdom.7–9
Jutel et al.10 have demonstrated that, given the very large
numbers of people now affected by allergic conditions, expansion
of allergy services delivered within ‘specialist settings’ is not a
viable proposition. Rather, they suggest that there is a need to
develop provision of allergy care within community settings. A
report by the Children’s and Young People’s Allergy Network
Scotland in 2013 found that, across Scotland, primary care
practitioners did not feel they have the skills or knowledge to
provide good quality allergy care, especially around diagnostic
testing for allergy, and the ability to interpret the results.11
An earlier pilot primary care-based allergy service in England,
run by a specialist allergy nurse and a GP with a special interest in
respiratory disease and allergy, showed that a primary care
intervention for allergy could effectively deal with the majority of
cases of allergy seen in primary care, resulting in a reduction in
inappropriate referrals into secondary care, an increase in self-
supported care for patients and a saving in costs.12 These data
however come from an uncontrolled study and therefore need to
be interpreted with caution. A more recent study by Smith et al.13
found that a large percentage of referrals, which would have
otherwise have been seen in secondary care, could adequately be
dealt with in primary care by a practitioner with a specialist
interest in allergy. Findings from a recent systematic review
support the need for alternative models of allergy care provision.14
Systematic reviews of disease-speciﬁc nurse-led clinics have
shown high levels of patient satisfaction; however, there remains
a need for experimental trials to improve the level of
evidence.15,16 In response to these ﬁndings, we are proposing a
novel allergy service intervention that is nurse-led and primary
care-based to improve the patient pathway and access to early
allergy diagnosis and management.
The primary aims of this trial are to assess the feasibility of
delivering and evaluating a nurse-led allergy clinic in a primary
care setting in Scotland and to estimate the impact on disease-
speciﬁc quality of life in patients referred to the service. The
secondary aim is to measure the acceptability of the service to
patient/carers and healthcare professionals (HCPs).
DISCUSSION
At the time of submission, we have recruited two hub practices
who are receiving referrals from 21 of the 37 spoke practices, and
one practice which is hosting a clinic for their own patients. There
have been 265 referrals to the service, and 214 have been seen in
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the nurse-led clinic. Recruitment started in July 2017 and will
continue until January 2020, when it is anticipated we will have
reached our target sample size of 250 patients who have
completed study follow-up.
METHODS
Design
This is a feasibility trial of a single group assigned to a nurse-led allergy
clinic in primary care. The trial was registered on ClinicalTrials.gov
reference NCT03826953 on 1 February 2019 (https://clinicaltrials.gov/ct2/
show/NCT03826953?term=NCT03826953&rank=1).
Setting
Nurse-led allergy clinics are being established in the South West and South
East localities of the Edinburgh Health and Social Care Partnership,
Scotland.
Ethical approval
South East Scotland Research Ethics committee approval was obtained
(REC ref: 17/SS/0057).
Recruitment of practices
A hub and spoke model was chosen for this trial, where hub practices act
as the host for the nurse-led allergy clinic and spokes are the practices that
can refer patients to these hubs. Eight general practices in the Edinburgh
Health and Social Care Partnership newly formed south-east area cluster
were approached by email to be hubs. This newly established cluster
group has 20 general practices serving an estimated population of 134,000
patients, with a range of patient demographics. Two practices expressed
an interest and were visited by the allergy nurse to explain the
requirements for hosting the clinics. One practice agreed to operate as a
hub practice, accepting referrals from spoke practices in the cluster, and
the other agreed to host the clinics, but accepting only internal referrals.
Subsequently, a third hub practice was recruited in the south-west area of
Edinburgh with 17 practices acting as spokes serving an estimated
population of 135,000 patients. Locality managers distributed study
information packs to all practices in their cluster, and this was then
followed up with an email to individual clinicians detailing the inclusion
criteria for referrals, and a referral proforma. Regular emails are sent out
reminding clinicians of the nurse-led allergy service.
Recruitment of participants
All adults, young people and children who ﬁt the eligibility criteria from the
spoke practices can be referred to the nurse-led allergy clinic. Referrals are
accepted from all HCPs who manage patients with allergies, including GPs,
practice nurses and health visitors. The HCP will select the appropriate
patients for referral, using an inclusion criteria checklist, and ask if they
wish to attend the allergy clinic, advising patients and their carers that the
nurse-led allergy clinic is part of a research study. On attendance at the
clinic, patients/patient’s guardian are advised that they will need to provide
written consent to take part in the study. If the patient does not wish to
take part in the research project, they will be seen by their HCP as usual.
Eligibility criteria
The inclusion criteria are:
● Children aged <36 months with suspected food allergy.
● Children aged <36 months with moderate-to-severe atopic eczema
not responding to standard treatment.
● Children and young people up to 16 years of age with suspected
allergic rhinitis symptoms are not responsive to a combination of oral
antihistamines and nasal steroids.
● Young people and adults (from 16 years of age) with a history of
anaphylaxis or suspected anaphylaxis.
● Able to give informed consent.
The exclusion criteria are:
● Children aged <36 months with suspected or conﬁrmed non-IgE-mediated
food allergy presenting primarily with gastrointestinal symptoms.
● Single urticarial reactions without obvious triggers.
● Non-allergic chronic urticaria.
● Drug allergy.
● Well-controlled allergic rhinitis, asthma or atopic eczema.
● Mild-to-moderate atopic eczema without any obvious allergic trigger.
● Localised insect sting reactions.
● Unable to give informed consent.
The intervention
The intervention is a nurse-led allergy service in primary care. The nurses
have a postgraduate qualiﬁcation in allergy and extensive experience of
secondary care allergy clinics and are supported when necessary by a team
of specialist services, including paediatric and adult allergy, dermatology,
ear, nose and throat, respiratory, and ophthalmology. Referring HCPs are
asked to complete a referral proforma and a referral sheet for each eligible
patient, which is sent via secure National Health Service (NHS) email to the
allergy nurse. Referrals are triaged by the allergy nurse according to the
inclusion/exclusion criteria, and allocated an appointment by phone and
letter/email. The ~45-min appointment includes an explanation of the
study, taking written consent, and completion of baseline questionnaires
assessing disease-speciﬁc quality of life and costs incurred by the patients/
carers (see outcome measures below). The nurse then completes an
allergy-focused history and clinical examination. Following this, the nurse
will carry out investigations such as skin prick testing, give advice (written
and oral) to support the management of allergies, including demonstration
of medical devices (e.g. adrenaline auto-injectors, inhalers) and, if required,
recommend medication(s). A letter summarising the consultation is then
sent to the referring HCP including details of the medication to prescribe
and the rationale for prescribing these items. The participants are then
discharged back to the care of their referring HCP once they have seen the
allergy nurse and have a diagnosis conﬁrmed or refuted (see Fig. 1).
If, on examination, the allergy nurse feels the participant has multiple
severe allergies or requires specialist hospital-based assessment, the
participant will be advised that they will require referral onto secondary
care (Fig. 2). Where appropriate, the allergy nurse will refer participants
directly to specialists within secondary care. Where the local policy will not
support nurse-led referrals, the nurse practitioner will make recommenda-
tions to the GP for the referral of the participant to the appropriate
specialist services. Participants who have been seen in secondary care will
be referred back to their usual HCP for long-term management. Long-term
clinical follow-up will not be offered; some short-term follow-up may,
however, be offered if deemed appropriate. All participants will return to
their usual HCP for follow-up and long-term management.
Adverse events
The allergy nurses will ensure that when performing skin prick testing,
rescue medications are available at the time of the clinic in the unlikely
event of a medical emergency. In the case of an adverse event, the allergy
nurse has a responsibility to attend to the safety of the participant and
report the incident as soon as is practicable to the on-call GP and practice
manager and follow local reporting procedures within the practice. The
allergy nurse will also keep a log of any adverse event or adverse reactions.
Any serious adverse event or reactions will be reported immediately to the
Academic and Clinical Central Ofﬁce for Research and Development17
following the standard operating procedure.
Outcome measures
This feasibility trial focuses on the ability to set up a new service in primary
care, with a novel ‘hub and spoke’ referral model for patients with allergic
disease. Prior to a pilot randomised controlled trial, it is important to assess
the ability to recruit patients via this new service, and establish recruitment
and retention rates and questionnaire response rates for future sample size
estimates. The primary outcomes are:
● Recruitment of practices to facilitate establishing the new service and
make referrals.
● Referral and consultation rates for nurse-led allergy clinic and
retention rates.
● The change in disease-speciﬁc quality of life questionnaires between
baseline and 6–12 weeks post intervention.
M. Kelman et al.
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The following disease-speciﬁc quality of life questionnaires will be
completed at baseline prior to the clinical intervention and at 6–12 weeks
post intervention by telephone or email, and face to face for those patients
who require a follow-up clinic appointment.
● Dermatology
○ Infants’ Dermatitis Quality Of Life Index18
● Allergic rhinitis
○ Mini Rhinitis Quality of Life Questionnaire19
● Food allergy and anaphylaxis
○ Food Allergy Quality of Life Questionnaire – Parent Form (children
aged 0–12)20
○ Food Allergy Quality of Life Questionnaire – Teenager Form
(13–17 years)21
○ Food Allergy Quality of Life Questionnaire – Adult form22
The secondary outcomes are:
● Patient satisfaction, measured immediately post intervention and
6–12 weeks post intervention by questionnaire.
● Referring HCP satisfaction measured after 1 year of the start of the
nurse-led allergy clinics by questionnaire.
● Costs incurred by patients/carers.
A subset of referring HCPs, practice managers and patients/carers will be
invited to take part in a semi-structured interview to gain in-depth insight
into the feasibility of setting up and referring to the clinic, and to explore
expectations and experiences of attending the nurse-led primary care
allergy clinic.
Sample size
The sample size for this feasibility trial was informed by an English pilot
study,12 which over a 9-month period recruited 141 patients to a primary
care allergy clinic. We estimate that, taking account of the available time
and resources for this study, ~250 patients with completed study follow-up
will provide data to inform deliberations to proceed to a pilot randomised
controlled trial.
We will interview up to ten HCPs/professional stakeholders, and 20
patients/carers who attend the nurse-led allergy clinic, to cover the
experiences of patients and carers with a range of ages and allergic
conditions.
Descriptive analysis
We will describe the number of practices approached to act as hubs and
spokes and the number recruited. The characteristics of referring practices
in terms of number of patients referred, practice list size and deprivation
score will be reported. For patients we will describe the number
approached and recruited, age, sex and referring condition. We will report
the retention rate for follow-up. For disease-speciﬁc quality of life, the
difference in the disease-speciﬁc quality of life score at baseline and post
intervention will be descriptively compared without any formal statistical
testing. Patient and professional satisfaction with the service will be
reported. Costs (such as travel and time off work) incurred by the patients/
carers will be reported.
Referrals are forwarded directly to nurse-led allergy clinic – To be triaged
Paent requires 
ongoing management 
Referral is not eligible for 
allergy clinic  
Referral doesn’t fulﬁl criteria  
Refer back to referring HCP 
with explanaon  
Appointment allocated for nurse-
led allergy clinic by allergy nurse 
Advice/ treatment given no 
further management 
required/resoluon of 
symptoms  
Refer to secondary care specialists  
Secondary care specialists  
• Paediatric allergy team 
(Consultant/Nurse/Dietician)  
• Ear, Nose and Throat   
• Ophthalmology  
• Dermatology  
• Respiratory  
Paent is complex and requires 
to be seen in secondary care 
Paent discharged back to 
referring health care 
professional with a leer 
documenng the 
consultaon  
Review appointments 
arranged for nurse-led 
allergy clinic unl 
discharge back to HCP  
Referral is eligible for allergy clinic  
Paent aends usual health care professional (HCP) with: 
• History of allergic symptoms requiring speciﬁc diagnosis or 
• Unsasfactory response to inial therapy 
Paent aends nurse-led allergy clinic
Diagnosis to conﬁrm or refute allergic condion, treatment/advice 
iniated   
Paent does not agree to take part
Connues to be seen by own HCP as usual  
Paent agrees to be referred into allergy clinic
HCP completes agreed referral proforma and checklist 
and sends though secure email  
Fig. 1 Referral process into the nurse-led allergy clinic.
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Qualitative analysis
Interviews will be digitally recorded, transcribed verbatim and anonymised
and transferred to NVivo (version 11) for coding. The thematic analysis23
will be iterative and ongoing, in that insights gained from the early
interviews will be used to guide data generation in later interviews. The
formal thematic coding will be framed around both the research questions
and themes arising from the data. Ma.K. will code all the transcripts and
the evolving analysis will be reviewed by the study group at their quarterly
meetings in order to include a range of interpretative perspectives.
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Paent visits health care professional (HCP) 
• HCP checks paent is suitable for nurse-led allergy clinic (checked against eligibility criteria).  
• HCP advises paent of allergy clinical intervenon - research project and need for consent to aend   
Allergy nurse receives referral – phones paent to book clinic appointment 
Baseline - Inial visit to nurse-led allergy clinic  
Paent/carer to complete  
• Consent form    
• Baseline quesonnaires including disease 
speciﬁc QOL and paent cost   
• Post-consultaon sasfacon survey 
6–12 weeks later – or aer paent has been discharged
back to care of health care professional  
Paent to complete      
• Sasfacon survey  
• Disease-speciﬁc QOL quesonnaire  
• Paent Cost quesonnaire 
Interview - If appropriate researcher will contact paent 
to parcipate in interview to gather feedback  
At 12 weeks aer start of clinic 
Health care professional completes 
consent process  
Qualitave researcher contacts health 
care professional to arrange interview to 
gather feedback  
Health care professional  Paent/carer  
Paent does not agree to take part 
Connues to be seen by own HCP  
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Paent referred to nurse-led allergy clinic 
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